Jesús Mosquera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jesús Mosquera has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Pedreañez
Catedra de Inmunologia, Escuela de Bioanalisis, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
31 shared publications - Yenddy Carrero
Universidad ECOTEC, Samborondón, EC092302, Ecuador
11 shared publications - Juan Pablo Hernandez-Fonseca
Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
8 shared publications Ninoska Viera
D Institute for Investigation, Faculty of Odontology, Universidad of Zulia , Maracaibo , Venezuela
8 shared publicationsRenata Vargas
Instituto de Investigaciones Clínicas “Dr Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
7 shared publications- Renata Vargas
Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
7 shared publications
Latest Publications
- 31 August 2026
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 27
Severe dengue evolution in obesity: Possible role of angiotensin II
Introduction: Obesity is a risk factor for infections and severe comorbidities. Patients with obesity infected with dengue virus (DENV) may have a severe course of the disease. This is attributed to several factors, including immunomodulation, endothelial damage, production of pro-inflammatory cytokines, and cellular accumulation of lipids, factors that promote viral replication. Angiotensin II (Ang II) has been linked to obesity and DENV biology, but its role in dengue severity in patients with obesity remains understudied. Method: The literature was searched in databases by using the search engines (PubMed, SCOPUS, Web of Sciences, Science Direct, and Google Scholar) Conclusions: This review highlights factors present in obesity such as the intracellular lipid droplets, proteins such as MIF (macrophage migration inhibitory factor), and furin (important in DENV replication), presence of chymase (linked to Ang II synthesis), caveolin-1 (related to obesity, dengue, and Ang II) and the different entry receptors of DENV as factors involved in the possible action of Ang II in patients with obesity and dengue. Pro-inflammatory actions of Ang II can increase the inflammatory effects of DENV and the obesity associated chronic inflammatory state, and may be contributing to explain in part the severe progression of dengue in individuals with obesity.
- 31 August 2026
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 27
Severe dengue evolution in obesity: Possible role of angiotensin II
Introduction: Obesity is a risk factor for infections and severe comorbidities. Patients with obesity infected with dengue virus (DENV) may have a severe course of the disease. This is attributed to several factors, including immunomodulation, endothelial damage, production of pro-inflammatory cytokines, and cellular accumulation of lipids, factors that promote viral replication. Angiotensin II (Ang II) has been linked to obesity and DENV biology, but its role in dengue severity in patients with obesity remains understudied. Method: The literature was searched in databases by using the search engines (PubMed, SCOPUS, Web of Sciences, Science Direct, and Google Scholar) Conclusions: This review highlights factors present in obesity such as the intracellular lipid droplets, proteins such as MIF (macrophage migration inhibitory factor), and furin (important in DENV replication), presence of chymase (linked to Ang II synthesis), caveolin-1 (related to obesity, dengue, and Ang II) and the different entry receptors of DENV as factors involved in the possible action of Ang II in patients with obesity and dengue. Pro-inflammatory actions of Ang II can increase the inflammatory effects of DENV and the obesity associated chronic inflammatory state, and may be contributing to explain in part the severe progression of dengue in individuals with obesity.
- 16 May 2026
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (3) , e70165
Possible Effects of C‐Reactive Protein in the Central Nervous System During Venezuelan Equine Encephalitis Virus Infection
Venezuelan equine encephalitis virus (VEEV) is an alphavirus vectored by mosquitos. It can cause disease in equines and humans characterised by a febrile illness that may progress into encephalitis. Replication of VEEV in the central nervous system induces activation of glial cells and neurons, compromising the blood‐brain barrier (BBB) and inducing a state of neuroinflammation. This inflammation can lead to symptoms such as confusion, seizures, and coma, and sustained inflammation contributes to neurodegeneration. C‐reactive protein (CRP) is a biomarker that has previously been associated with inflammation and infection. It is now known that its functions are related to various brain disorders. Circulating increased CRP levels correlate with alterations in brain structure and metabolism associated with cognitive vulnerability, suggesting the effect of CRP on brain cell biology. However, the fact that alphavirus (including VEEV) infection is accompanied by increased CRP production makes it likely that VEEV infection induces the production of this protein systemically and/or mediated by the activation of brain cells. This review highlights a role of CRP in the brain parenchyma, influencing various aspects of VEEV brain infection such as general inflammation, BBB permeability, hypoxia, apoptosis, interaction with different brain cells, and brain metabolism. The influence of CRP in the brain may exacerbate the inflammatory process induced by VEEV. The existence of several drugs with anti‐CRP effects opens their use in the treatment of VEEV brain infection.
- 16 May 2026
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (3) , e70165
Possible Effects of C‐Reactive Protein in the Central Nervous System During Venezuelan Equine Encephalitis Virus Infection
Venezuelan equine encephalitis virus (VEEV) is an alphavirus vectored by mosquitos. It can cause disease in equines and humans characterised by a febrile illness that may progress into encephalitis. Replication of VEEV in the central nervous system induces activation of glial cells and neurons, compromising the blood‐brain barrier (BBB) and inducing a state of neuroinflammation. This inflammation can lead to symptoms such as confusion, seizures, and coma, and sustained inflammation contributes to neurodegeneration. C‐reactive protein (CRP) is a biomarker that has previously been associated with inflammation and infection. It is now known that its functions are related to various brain disorders. Circulating increased CRP levels correlate with alterations in brain structure and metabolism associated with cognitive vulnerability, suggesting the effect of CRP on brain cell biology. However, the fact that alphavirus (including VEEV) infection is accompanied by increased CRP production makes it likely that VEEV infection induces the production of this protein systemically and/or mediated by the activation of brain cells. This review highlights a role of CRP in the brain parenchyma, influencing various aspects of VEEV brain infection such as general inflammation, BBB permeability, hypoxia, apoptosis, interaction with different brain cells, and brain metabolism. The influence of CRP in the brain may exacerbate the inflammatory process induced by VEEV. The existence of several drugs with anti‐CRP effects opens their use in the treatment of VEEV brain infection.
- 14 November 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (4) , 291-301
C-reactive protein as an effector molecule in dengue pathogenesis: a review
Dengue is an infectious disease caused by the bite of a mosquito (Aedes aegypti) infected with the dengue virus and represents the world’s most common arboviral infection. Dengue is most common in tropical and subtropical areas and it has become a threat to human life. This disease induces high immune system activation resulting in an inflammatory process. C-reactive protein (CRP) as a marker of inflammation in various diseases has been studied; however, there are few studies that analyse it as an effector molecule in inflammatory disease pathogenesis. This review summarizes the current published literature through 2025 (on PubMed, Embase and Web of Science) regarding the factors that affect the pathogenesis of dengue mediated by CRP. The role of CRP in dengue pathogenesis may be related to its effects on complement activation, alterations of the coagulation system, thrombocytopaenia, alteration of vascular permeability, induction of liver damage and its interaction with Fc receptors and dendritic cells. These data strongly suggest a role for CRP in dengue pathogenesis.
- 14 November 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (4) , 291-301
C-reactive protein as an effector molecule in dengue pathogenesis: a review
Dengue is an infectious disease caused by the bite of a mosquito (Aedes aegypti) infected with the dengue virus and represents the world’s most common arboviral infection. Dengue is most common in tropical and subtropical areas and it has become a threat to human life. This disease induces high immune system activation resulting in an inflammatory process. C-reactive protein (CRP) as a marker of inflammation in various diseases has been studied; however, there are few studies that analyse it as an effector molecule in inflammatory disease pathogenesis. This review summarizes the current published literature through 2025 (on PubMed, Embase and Web of Science) regarding the factors that affect the pathogenesis of dengue mediated by CRP. The role of CRP in dengue pathogenesis may be related to its effects on complement activation, alterations of the coagulation system, thrombocytopaenia, alteration of vascular permeability, induction of liver damage and its interaction with Fc receptors and dendritic cells. These data strongly suggest a role for CRP in dengue pathogenesis.
- 19 October 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 276, 156274
Role of C-reactive protein in cervical intraepithelial neoplasia/cancer
- 19 October 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 276, 156274
Role of C-reactive protein in cervical intraepithelial neoplasia/cancer
- Open Access
- 1 September 2025
- Published by Universidad del Zulia in Investigación Clínica
- Vol. 66 (3) , 231-233
EDITORIAL Plagio, similitudes e inteligencia artificial en la evaluación de trabajos científicos.
The reliance on programs that measure percentages of plagiarism (based on the concept of plagiarism), similarities, or AI content—without a thorough analysis of the manuscript’s quality—reflects an editorial approach that prioritizes new technology guidelines over the actual quality of the work. Such measures should not serve as a barrier to the submission of research papers for review by qualified reviewers who can assess the quality of the report.
- 1 September 2025
- Published by Universidad del Zulia in Investigación Clínica
- Vol. 66 (3) , 231-233
Open AccessEDITORIAL Plagio, similitudes e inteligencia artificial en la evaluación de trabajos científicos.
The reliance on programs that measure percentages of plagiarism (based on the concept of plagiarism), similarities, or AI content—without a thorough analysis of the manuscript’s quality—reflects an editorial approach that prioritizes new technology guidelines over the actual quality of the work. Such measures should not serve as a barrier to the submission of research papers for review by qualified reviewers who can assess the quality of the report.
- 2 May 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (3) , e70040
Role of Angiotensin II in Venezuelan Equine Encephalitis: Narrative Review
Venezuelan equine encephalitis virus (VEEV) is an alphavirus in the family Togaviridae, transmitted by a mosquito bite and is highly infectious in aerosol form. Inflammation plays a role of antiviral response as well as development of lethal encephalitis. Infection through a mosquito bite is biphasic, beginning with an inflammatory process and viral replication in different organs with subsequent infiltration to the central nervous system (CNS), inducing encephalitis. The direct route is through inhalation of aerosols containing the virus with direct brain infection through the olfactory nerve. Significant damage is due to exacerbated inflammation in the host. Angiotensin II (Ang II) is a molecule with high pro‐inflammatory capacity, which has been found to be upregulated in the brain of VEEV‐infected rats, suggesting its role in the pathogenesis of this disease. Limited information regarding the association of Ang II expression with VEEV brain infection has been reported. The aim of this review is to highlight published reports indicating a possible association between Ang II expression and VEEV‐induced encephalitis. Several studies reflect a possible expression and function of Ang II during VEEV infection. Factors such as the relationship of Ang II with proteins involved in viral replication and entry into the cell (furin, Rab5, Rab7), activation of protein kinase C (necessary for the phosphorylation of VEEV), presence of microRNAs related to viral biology, increased permeability of the blood‐brain barrier, and use of transcription pathways common to Ang II and VEEV, may conceivable an association of Ang II with the pathogenesis of VEEV encephalitis.
- 2 May 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (3) , e70040
Role of Angiotensin II in Venezuelan Equine Encephalitis: Narrative Review
Venezuelan equine encephalitis virus (VEEV) is an alphavirus in the family Togaviridae, transmitted by a mosquito bite and is highly infectious in aerosol form. Inflammation plays a role of antiviral response as well as development of lethal encephalitis. Infection through a mosquito bite is biphasic, beginning with an inflammatory process and viral replication in different organs with subsequent infiltration to the central nervous system (CNS), inducing encephalitis. The direct route is through inhalation of aerosols containing the virus with direct brain infection through the olfactory nerve. Significant damage is due to exacerbated inflammation in the host. Angiotensin II (Ang II) is a molecule with high pro‐inflammatory capacity, which has been found to be upregulated in the brain of VEEV‐infected rats, suggesting its role in the pathogenesis of this disease. Limited information regarding the association of Ang II expression with VEEV brain infection has been reported. The aim of this review is to highlight published reports indicating a possible association between Ang II expression and VEEV‐induced encephalitis. Several studies reflect a possible expression and function of Ang II during VEEV infection. Factors such as the relationship of Ang II with proteins involved in viral replication and entry into the cell (furin, Rab5, Rab7), activation of protein kinase C (necessary for the phosphorylation of VEEV), presence of microRNAs related to viral biology, increased permeability of the blood‐brain barrier, and use of transcription pathways common to Ang II and VEEV, may conceivable an association of Ang II with the pathogenesis of VEEV encephalitis.
- 5 April 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (3) , 469-482
Mechanisms of angiotensin II to induce depression in diabetes
The expression of angiotensin II (Ang II) has been reported in diabetes associated with hypertension and inflammatory processes. It has also been reported a link between Ang II, depression and diabetes; however, underlying mechanisms of Ang II-induced depression in this disease remain unclear. This review focuses on the possible mechanisms of Ang II to induce depression in diabetes. Ang II can induce pro-inflammatory events that activate indoleamine 2,3-dioxygenase and kynurenine monooxygenase. These activated enzymes act by decreasing the production of serotonin and increasing the production of quinolinic acid which acts on the N-methyl-d-aspartate receptor and the amino-methyl propionic acid receptor inducing decreased brain-derived neurotrophic factor (BDNF) expression and depression. Ang II can also induce the production of galectin 3 which has a depressant effect. Neuroinflammation induced by Ang II during diabetes can alter brain cells, event associated with functional disorders and depression. Furthermore, Ang II is capable of inducing oxidative stress in diabetes linked to depressive behaviors. In conclusion, Ang II has the potential to induce depression during diabetes through different mechanisms that involve inflammatory processes, oxidative stress, the production of galectin 3, and decrease in serotonin and BDNF. These findings open the possibility of using anti-Ang II drugs for the treatment of depressive behavior in diabetes.
- 5 April 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (3) , 469-482
Mechanisms of angiotensin II to induce depression in diabetes
The expression of angiotensin II (Ang II) has been reported in diabetes associated with hypertension and inflammatory processes. It has also been reported a link between Ang II, depression and diabetes; however, underlying mechanisms of Ang II-induced depression in this disease remain unclear. This review focuses on the possible mechanisms of Ang II to induce depression in diabetes. Ang II can induce pro-inflammatory events that activate indoleamine 2,3-dioxygenase and kynurenine monooxygenase. These activated enzymes act by decreasing the production of serotonin and increasing the production of quinolinic acid which acts on the N-methyl-d-aspartate receptor and the amino-methyl propionic acid receptor inducing decreased brain-derived neurotrophic factor (BDNF) expression and depression. Ang II can also induce the production of galectin 3 which has a depressant effect. Neuroinflammation induced by Ang II during diabetes can alter brain cells, event associated with functional disorders and depression. Furthermore, Ang II is capable of inducing oxidative stress in diabetes linked to depressive behaviors. In conclusion, Ang II has the potential to induce depression during diabetes through different mechanisms that involve inflammatory processes, oxidative stress, the production of galectin 3, and decrease in serotonin and BDNF. These findings open the possibility of using anti-Ang II drugs for the treatment of depressive behavior in diabetes.
- Open Access
- 18 October 2024
- Published by MDPI AG in Preprints.org
Neutrophil/Lymphocyte Ratio and C-Reactive Protein in Patients with COVID-19: Correlations in Deceased and Surviving Patients
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with inflammatory process activation. Among the elements involved in the inflammatory process are leukocytes and cytokine production. Various studies have determined the importance of the neutrophil-to-lymphocyte ratio (NLR) in different inflammatory processes. C-reactive protein (CRP) is involved in several infectious processes as a marker of inflammation. This study aims to determine the values of NLR and CRP in COVID-19 patients and controls and to determine these values in COVID-19 survivors and deceased patients. Overall, during COVID-19, lymphocyte counts, NLR, and CRP values were significantly increased. Furthermore, it was observed that during the disease, there were more positive correlations between the different inflammatory parameters studied than between the controls. The results show that surviving patients had increased lymphocyte counts and CRP content compared to deceased patients; however, the latter presented the highest NLR values and the lowest lymphocyte values, establishing a prognostic value of severe evolution. The number of significant correlations observed in surviving and deceased patients was similar. This study suggests the importance of leukocytes and CRP in COVID-19 and a possible predictive value for the severe evolution of NLR in the disease.
- 18 October 2024
- Published by MDPI AG in Preprints.org
Open AccessNeutrophil/Lymphocyte Ratio and C-Reactive Protein in Patients with COVID-19: Correlations in Deceased and Surviving Patients
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with inflammatory process activation. Among the elements involved in the inflammatory process are leukocytes and cytokine production. Various studies have determined the importance of the neutrophil-to-lymphocyte ratio (NLR) in different inflammatory processes. C-reactive protein (CRP) is involved in several infectious processes as a marker of inflammation. This study aims to determine the values of NLR and CRP in COVID-19 patients and controls and to determine these values in COVID-19 survivors and deceased patients. Overall, during COVID-19, lymphocyte counts, NLR, and CRP values were significantly increased. Furthermore, it was observed that during the disease, there were more positive correlations between the different inflammatory parameters studied than between the controls. The results show that surviving patients had increased lymphocyte counts and CRP content compared to deceased patients; however, the latter presented the highest NLR values and the lowest lymphocyte values, establishing a prognostic value of severe evolution. The number of significant correlations observed in surviving and deceased patients was similar. This study suggests the importance of leukocytes and CRP in COVID-19 and a possible predictive value for the severe evolution of NLR in the disease.
- 30 August 2024
- Published by Wiley in Reviews in Medical Virology
- Vol. 34 (5) , e2577
Role of Gut Microbiota in Dengue
Dengue is a disease caused by a flavivirus (DENV) and transmitted by the bite of a mosquito, primarily the Aedes aegypti and Aedes albopictus species. Previous studies have demonstrated a relationship between the host gut microbiota and the evolution of dengue. It seems to be a bidirectional relationship, in which the DENV can affect the microbiota by inducing alterations related to intestinal permeability, leading to the release of molecules from microbiota dysbiosis that can influence the evolution of dengue. The role of angiotensin II (Ang II) in the microbiota/dengue relationship is not well understood, but it is known that the renin‐angiotensin system (RAS) is present in the intestinal tract and interacts with the gut microbiota. The possible effect of Ang II on the microbiota/Ang II/dengue relationship can be summarised as follows: the presence of Ang II induced hypertension, the increase in angiotensinogen, chymase, and microRNAs during the disease, the induction of vascular dysfunction, the production of trimethylamine N‐oxide and the brain/microbiota relationship, all of which are elements present in dengue that could be part of the microbiota/Ang II/dengue interactions. These findings suggest the potential use of Ang II synthesis blockers and the use of AT1 receptor antagonists as therapeutic drugs in dengue.
- 30 August 2024
- Published by Wiley in Reviews in Medical Virology
- Vol. 34 (5) , e2577
Role of Gut Microbiota in Dengue
Dengue is a disease caused by a flavivirus (DENV) and transmitted by the bite of a mosquito, primarily the Aedes aegypti and Aedes albopictus species. Previous studies have demonstrated a relationship between the host gut microbiota and the evolution of dengue. It seems to be a bidirectional relationship, in which the DENV can affect the microbiota by inducing alterations related to intestinal permeability, leading to the release of molecules from microbiota dysbiosis that can influence the evolution of dengue. The role of angiotensin II (Ang II) in the microbiota/dengue relationship is not well understood, but it is known that the renin‐angiotensin system (RAS) is present in the intestinal tract and interacts with the gut microbiota. The possible effect of Ang II on the microbiota/Ang II/dengue relationship can be summarised as follows: the presence of Ang II induced hypertension, the increase in angiotensinogen, chymase, and microRNAs during the disease, the induction of vascular dysfunction, the production of trimethylamine N‐oxide and the brain/microbiota relationship, all of which are elements present in dengue that could be part of the microbiota/Ang II/dengue interactions. These findings suggest the potential use of Ang II synthesis blockers and the use of AT1 receptor antagonists as therapeutic drugs in dengue.